HealthDay News — The US Food and Drug Administration (FDA) has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) as a first-line treatment for adults with unresectable or metastatic hepatocellular ...

HealthDay News — The new International League Against Epilepsy (ILAE) definition of epilepsy results in a higher frequency of epilepsy diagnosis and treatment, according to a study published in ...

The NIH already spends more than $300 million each year studying autism. It’s not clear how Kennedy’s new study will differ, and HHS has not released further details, The Associated Press said. Many ...

Both the FDA and Novo Nordisk are advising patients and providers to check their supplies of Ozempic for counterfeit product. Individuals in possession of a counterfeit product are urged to call Novo ...

The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

Researchers conducted a longitudinal cohort study to assess the effect of gender-affirming hormone therapy on depression risk among a diverse sample of TGD adults.

In the past, experts from the CDC’s EpiAid program have provided short-term help to local agencies dealing with urgent public health issues.

After proper training on subcutaneous injection technique, the prefilled syringe may be administered by the patient or caregiver.

These new steps dovetail with a rapid rise in measles cases this year, with more than 600 cases reported across at least 21 states.

The AHA has published a scientific statement regarding disparities in current pulmonary embolism management and outcomes.

Substantially elevated GAS incidence rates seen in people experiencing homelessness, people who inject drugs, long-term care facility residents.